1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71) does not disturb fracture healing process in rat's femoral fracture model.

被引：0

|

作者：

Mori, S ^{[1
]}

Cao, Y ^{[1
]}

Miyamoto, K ^{[1
]}

Iwata, K ^{[1
]}

Mahiba, T ^{[1
]}

Akiyama, T ^{[1
]}

Komatsubara, S ^{[1
]}

Manabe, T ^{[1
]}

Norimatsu, H ^{[1
]}

机构：

[1] Kagawa Univ, Fac Med, Kagawa, Japan

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S323 / S323

页数：1

相关论文

共 42 条

[41] Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
Satoshi Takeda
Susan Y. Smith
Tatsuya Tamura
Hitoshi Saito
Fumiaki Takahashi
Rana Samadfam
Solomon Haile
Nancy Doyle
Koichi Endo
Calcified Tissue International, 2015, 96 : 45 - 55
[42] 2-Methylene-19-nor-20(S)-1α-hydroxy-bishomopregnacalciferol [20(S)-2MbisP], an analog of vitamin D3 [1,25(OH)2D3], does not stimulate intestinal phosphate absorption at levels previously shown to suppress parathyroid hormone
Williams, Katie B.
DeLuca, Hector F.
STEROIDS, 2008, 73 (12) : 1277 - 1284

← 1 2 3 4 5 →